Dosage and administration
One tablet daily or as directed by a physician.
One tablet daily or as directed by a physician.
Prenatal Multivitamin/
Multimineral Tablets
63044-154-63
Rx Only
| WARNING: Accidental overdose of iron-containing prod-Ucts is a leading cause of fatal poisoning in children under 6. Keep this product out of the reach of children. In case of accidental overdose, call a doctor or poison control center immediately. |
INATAL Ultra is a white, dye free, oval oil-and-water-soluble multivitamin/multimineral tablet with calcium citrate and carbonyl iron.
Each tablet contains:
Vitamin A* . . . . . . . . . . . . . . . . . . . . . . . 2700 I.U.
Vitamin C (Ascorbic Acid) . . . . . . . . . . . . . . 120 mg
Calcium (Calcium Citrate) . . . . . . . . . . . . . 200 mg
Elemental Iron (Carbonyl Iron) . . . . . . . . . . . 90 mg
Vitamin D3 (Cholecalciferol) . . . . . . . . . . . . 400 I.U.
Vitamin E (dl-Alpha Tocopheryl Acetate) . . . . . 30 I.U.
Vitamin B1 (Thiamine Mononitrate) . . . . . . . . . 3 mg
Vitamin B2 (Riboflavin) . . . . . . . . . . . . . . . . 3.4 mg
Niacinamide . . . . . . . . . . . . . . . . . . . . . . . . 20 mg
Vitamin B6 (Pyridoxine HCI) . . . . . . . . . . . . . 20 mg
Folic Acid . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 mg
Vitamin B12 (Cyanocobalamin) . . . . . . . . . . 12 mcg
Iodine (Potassium Iodide) . . . . . . . . . . . . . 150 mcg
Zinc (Zinc Oxide) . . . . . . . . . . . . . . . . . . . . . 25 mg
Copper (Cupric Oxide) . . . . . . . . . . . . . . . . . 2 mg
Docusate Sodium . . . . . . . . . . . . . . . . . . . . 50 mg
*Input as Vitamin A palmitate and beta carotene.
INATAL Ultra ® is a multivitamin/multimineral nutritional supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers. Ultra NatalCare® can also be beneficial in improving the nutritional status of women prior to conception.
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Folic Acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.
NOTICE: Contact with moisture may produce surface discoloration or erosion of the tablet.
Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.
Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
Safety and effectiveness in pediatric patients have not been established.
Clinical studies on this product have not been performed in sufficient numbers of subjects aged 65 and over to determine whether elderly subjects respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal or cardiac function, and of concomitant disease or other drug therapy.
One tablet daily or as directed by a physician.
NDC 63044-154-63 Unit Dose Packs containing 10 tablets per card.
Store at controlled room temperature 15°-30°C (59°-86°F).
KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN.
Manufactured for
Nnodum Pharmaceutical
Cincinnati, Ohio 45229
| Class | Version | Type | Effective |
|---|---|---|---|
| ASCORBIC ACID Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CALCIUM Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20230427 |
| CHOLECALCIFEROL Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| COPPER Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CYANOCOBALAMIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| POTASSIUM CATION Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| PYRIDOXINE Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20170310 |
| VITAMIN A Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63044-154-01 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-cee5-621f-e053-dbdaa90a74ad | INATAL Ultra |
| 63044-154-63 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-cee5-621f-e053-dbdaa90a74ad | INATAL Ultra |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63044-154-01 | INATAL Ultra | 100 in 1 BOTTLE | TABLET, COATED | 100 | 4 | |
| 63044-154-63 | INATAL Ultra | 10 in 1 BOX, UNIT-DOSE | TABLET, COATED | 10 | 4 | |
| 63044-154-63 | INATAL Ultra | 10 in 1 BLISTER PACK | TABLET, COATED | 10 | 4 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63044-154-01 | EA - Each | 63044-154 | 4b22d994-b539-46bf-8f7d-021cea2f7efb | 1 | 2012-07-24 |
| 63044-154-63 | EA - Each | 63044-154 | 76d5757f-93f1-4df0-ad38-89eed9f667ca | 1 | 2012-07-24 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ALPHA-TOCOPHEROL ACETATE | ACTIVE INGREDIENT | 9E8X80D2L0 | 4 | |
| ASCORBIC ACID | ACTIVE INGREDIENT | PQ6CK8PD0R | 4 | |
| CALCIUM CITRATE | ACTIVE INGREDIENT | MLM29U2X85 | 4 | |
| CHOLECALCIFEROL | ACTIVE INGREDIENT | 1C6V77QF41 | 4 | |
| CUPRIC OXIDE | ACTIVE INGREDIENT | V1XJQ704R4 | 4 | |
| CYANOCOBALAMIN | ACTIVE INGREDIENT | P6YC3EG204 | 4 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | 4 | |
| FOLIC ACID | ACTIVE INGREDIENT | 935E97BOY8 | 4 | |
| IRON PENTACARBONYL | ACTIVE INGREDIENT | 6WQ62TAQ6Z | 4 | |
| NIACINAMIDE | ACTIVE INGREDIENT | 25X51I8RD4 | 4 | |
| POTASSIUM IODIDE | ACTIVE INGREDIENT | 1C4QK22F9J | 4 | |
| PYRIDOXINE HYDROCHLORIDE | ACTIVE INGREDIENT | 68Y4CF58BV | 4 | |
| RIBOFLAVIN | ACTIVE INGREDIENT | TLM2976OFR | 4 | |
| THIAMINE MONONITRATE | ACTIVE INGREDIENT | 8K0I04919X | 4 | |
| VITAMIN A | ACTIVE INGREDIENT | 81G40H8B0T | 4 | |
| ZINC OXIDE | ACTIVE INGREDIENT | SOI2LOH54Z | 4 | |
| ALPHA-TOCOPHEROL | ACTIVE MOIETY | H4N855PNZ1 | 4 | |
| ASCORBIC ACID | ACTIVE MOIETY | PQ6CK8PD0R | 4 | |
| CALCIUM | ACTIVE MOIETY | SY7Q814VUP | 4 | |
| CHOLECALCIFEROL | ACTIVE MOIETY | 1C6V77QF41 | 4 | |
| COPPER | ACTIVE MOIETY | 789U1901C5 | 4 | |
| CYANOCOBALAMIN | ACTIVE MOIETY | P6YC3EG204 | 4 | |
| DOCUSATE | ACTIVE MOIETY | M7P27195AG | 4 | |
| FOLIC ACID | ACTIVE MOIETY | 935E97BOY8 | 4 | |
| IRON | ACTIVE MOIETY | E1UOL152H7 | 4 | |
| NIACINAMIDE | ACTIVE MOIETY | 25X51I8RD4 | 4 | |
| POTASSIUM CATION | ACTIVE MOIETY | 295O53K152 | 4 | |
| PYRIDOXINE | ACTIVE MOIETY | KV2JZ1BI6Z | 4 | |
| RIBOFLAVIN | ACTIVE MOIETY | TLM2976OFR | 4 | |
| THIAMINE | ACTIVE MOIETY | X66NSO3N35 | 4 | |
| VITAMIN A | ACTIVE MOIETY | 81G40H8B0T | 4 | |
| ZINC | ACTIVE MOIETY | J41CSQ7QDS | 4 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 4 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | 4 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 4 | |
| MINERAL OIL | INACTIVE INGREDIENT | T5L8T28FGP | 4 | |
| POLYETHYLENE GLYCOL | INACTIVE INGREDIENT | 3WJQ0SDW1A | 4 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | 4 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | 4 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 4 | |
| VANILLIN | INACTIVE INGREDIENT | CHI530446X | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63044-154 | 63044-154-63, 63044-154-01 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| VANILLIN | VANILLIN | CHI530446X | TABLET, CHEWABLE / ORAL | 2.5 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, CHEWABLE / ORAL | 216 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CREAM / TOPICAL | 80 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUPPOSITORY / RECTAL | NA | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, EXTENDED RELEASE / ORAL | 117 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE / ORAL | 72 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET, COATED / ORAL | 123 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | PELLET / ORAL | 1140 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | CREAM / VAGINAL | 12 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 1576 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, EXTENDED RELEASE / ORAL | 5119 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE / RESPIRATORY (INHALATION) | NA | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | GEL / DENTAL | 1.47 %w/w | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | POWDER / RESPIRATORY (INHALATION) | NA | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, EXTENDED RELEASE / ORAL | 90 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET, CHEWABLE / ORAL | 6 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, FILM COATED / ORAL | NA | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | LOTION / TOPICAL | NA | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | SOAP / TOPICAL | 1 %w/w | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | INSERT, EXTENDED RELEASE / OPHTHALMIC | 0.4 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, COATED / ORAL | 920 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | DROPS / ORAL | NA | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET / BUCCAL | 6 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 99 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | FILM / BUCCAL | 3 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CREAM / VAGINAL | 1088 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | SOAP / TOPICAL | 6 %w/w | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | SUPPOSITORY / VAGINAL | NA | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, FOR SUSPENSION / ORAL | 278 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | GRANULE / ORAL | 629 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | DROPS / ORAL | NA | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE / ORAL | 2169 mg | ||
| VANILLIN | VANILLIN | CHI530446X | TABLET / ORAL | 12 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / SUBLINGUAL | 10 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | CAPSULE, COATED PELLETS / ORAL | 198 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | OINTMENT / TOPICAL | 15 %w/w | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | FILM, SOLUBLE / BUCCAL | 11 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OIL / TOPICAL | 43.29 %v/v | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, EXTENDED RELEASE / ORAL | 67 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | DROPS / ORAL | NA | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET / ORAL | 336 mg | ||
| VANILLIN | VANILLIN | CHI530446X | TABLET, EXTENDED RELEASE / ORAL | 3.4 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | SUPPOSITORY, EXTENDED RELEASE / INTRAUTERINE | 1 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | OINTMENT / TOPICAL | 14 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / SUBCUTANEOUS | 0.5 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUSPENSION / OPHTHALMIC | 0.1 %w/w | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | SUSPENSION / ORAL | 150 mg | ||
| VANILLIN | VANILLIN | CHI530446X | OINTMENT / TOPICAL | NA | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | SUSPENSION, EXTENDED RELEASE / ORAL | 0.08 mg/1ml | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / INTRAVITREAL | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SYSTEM / TOPICAL | 654.36 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | POWDER, FOR SUSPENSION / ORAL | 120 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 127 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 144 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, EXTENDED RELEASE / ORAL | 200 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | IMPLANT / SUBCUTANEOUS | 1.04 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, EXTENDED RELEASE / ORAL | 173 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 42 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 4b22195d-d683-4ced-ae90-2aa395765bf8 | 864fdaeb-a030-4ebd-93f1-a51d4e8eaa94 | 2009-10-26 | Warnings, Adverse reactions | 4b22195d-d683-4ced-ae90-2aa395765bf8 864fdaeb-a030-4ebd-93f1-a51d4e8eaa94 |
Adverse event summaries are temporarily unavailable. Other product information remains available.